Rani Therapeutics Holdings Inc (RANI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
106,682,000
EV to revenue ratio (TTM)
7.93
EV to ebitda
-1.423
Financial Performance
Revenue (TTM)
4,877,000
Gross profit (TTM)
4,877,000
EBITDA
-32,237,000
Profitability
Operating margin (TTM)
-517.00%
Profit margin
0.00%
Return on assets (TTM)
-53.00%
Return on equity (TTM)
-172.20%
Per Share Metrics
Revenue per share (TTM)
0.04
EPS
-0.13
Diluted EPS (TTM)
-0.13
Book value
0.35
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
21.87
Price to book ratio (TTM)
2.256
Growth
Quarterly earnings growth (YoY)
893.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.706